Cargando…

Inhibition of Nek2 by Small Molecules Affects Proteasome Activity

Background. Nek2 is a serine/threonine kinase localized to the centrosome. It promotes cell cycle progression from G2 to M by inducing centrosome separation. Recent studies have shown that high Nek2 expression is correlated with drug resistance in multiple myeloma patients. Materials and Methods. To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Lingyao, Carpenter, Kent, Mollard, Alexis, Vankayalapati, Hariprasad, Warner, Steven L., Sharma, Sunil, Tricot, Guido, Zhan, Fenghuang, Bearss, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182079/ https://www.ncbi.nlm.nih.gov/pubmed/25313354 http://dx.doi.org/10.1155/2014/273180

Ejemplares similares

NEK2 Promotes Aerobic Glycolysis in Multiple Myeloma Through Regulating Splicing of Pyruvate Kinase
por: Gu, Zhimin, et al.
Publicado: (2017)

Nek2 Is a Novel Regulator of B Cell Development and Immunological Response
por: Gu, Zhimin, et al.
Publicado: (2014)

NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma
por: Yang, Ye, et al.
Publicado: (2014)

Role of NEK2A in Human Cancer and Its Therapeutic Potentials
por: Xia, Jiliang, et al.
Publicado: (2015)

A Small-Molecule Inhibitor of PIM Kinases as a Potential Treatment for Urothelial Carcinomas()()
por: Foulks, Jason M., et al.
Publicado: (2014)

Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus
por: Kelly, Kevin R., et al.
Publicado: (2015)

High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma
por: Cheng, Yan, et al.
Publicado: (2023)

Molecular modeling and docking of small molecule inhibitors against NEK2
por: Ramachandran, Balaji, et al.
Publicado: (2016)

Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?
por: Franqui-Machin, Reinaldo, et al.
Publicado: (2015)

NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma
por: Hao, M, et al.
Publicado: (2017)

Kinase Inhibitor Profile for Human Nek1, Nek6, and Nek7 and Analysis of the Structural Basis for Inhibitor Specificity
por: Moraes, Eduardo Cruz, et al.
Publicado: (2015)

NEK2 induces autophagy‐mediated bortezomib resistance by stabilizing Beclin‐1 in multiple myeloma
por: Xia, Jiliang, et al.
Publicado: (2020)

VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma
por: Nadiminti, Kalyan, et al.
Publicado: (2017)

Advances in Proteasome Enhancement by Small Molecules
por: George, Dare E., et al.
Publicado: (2021)

Mechanistic basis of Nek7 activation through Nek9 binding and induced dimerization
por: Haq, Tamanna, et al.
Publicado: (2015)

Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma
por: Ramani, Vishnu C., et al.
Publicado: (2015)

Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
por: Gu, Chunyan, et al.
Publicado: (2018)

Correction to: Upregulation of FOXM1 leads to diminished drug sensitivity in myeloma
por: Gu, Chunyan, et al.
Publicado: (2019)

The NIMA-family kinase, Nek1 affects the stability of centrosomes and ciliogenesis
por: White, Mark C, et al.
Publicado: (2008)

Discovery of Novel Inhibitors Targeting Multi-UDP-hexose Pyrophosphorylases as Anticancer Agents
por: Yang, Yueqin, et al.
Publicado: (2020)

Mitotic Regulation by NEK Kinase Networks
por: Fry, Andrew M., et al.
Publicado: (2017)

Up to your NEK2 in CIN
por: Seachrist, Darcie D., et al.
Publicado: (2021)

An Autoinhibitory Tyrosine Motif in the Cell-Cycle-Regulated Nek7 Kinase Is Released through Binding of Nek9
por: Richards, Mark W., et al.
Publicado: (2009)

Characterization of the Human NEK7 Interactome Suggests Catalytic and Regulatory Properties Distinct from Those of NEK6
por: de Souza, Edmarcia Elisa, et al.
Publicado: (2014)

Multiple Myeloma Tumor Cells are Selectively Killed by Pharmacologically-dosed Ascorbic Acid
por: Xia, Jiliang, et al.
Publicado: (2017)

Patented small molecule inhibitors in the ubiquitin proteasome system
por: Guédat, Philippe, et al.
Publicado: (2007)

Methods to Discover and Evaluate Proteasome Small Molecule Stimulators
por: Coleman, Rachel A., et al.
Publicado: (2019)

Small-Molecule Inhibitors Targeting Proteasome-Associated Deubiquitinases
por: Moon, Seonghyeon, et al.
Publicado: (2021)

Chemical Genetic Screen Reveals a Role for Desmosomal Adhesion in Mammary Branching Morphogenesis
por: Basham, Kaitlin J., et al.
Publicado: (2013)

Genetic Analysis of Multiple Myeloma Identifies Cytogenetic Alterations Implicated in Disease Complexity and Progression
por: Li, Can, et al.
Publicado: (2021)

Geographic and Racial Disparities in Access to Chimeric Antigen Receptor–T Cells and Bispecific Antibodies Trials for Multiple Myeloma
por: Alqazaqi, Raghad, et al.
Publicado: (2022)

Enhancement of Proteasome Activity by a Small-Molecule Inhibitor of Usp14
por: Lee, Byung-Hoon, et al.
Publicado: (2010)

Physiological and Pathological Roles of Mammalian NEK7
por: Sun, Zhenzhen, et al.
Publicado: (2020)

New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing
por: Basei, Fernanda Luisa, et al.
Publicado: (2015)

NEK7 promotes gastric cancer progression as a cell proliferation regulator
por: Li, Yi-Ke, et al.
Publicado: (2021)

Alteration of mitochondrial biogenesis promotes disease progression in multiple myeloma
por: Zhan, Xin, et al.
Publicado: (2017)

CGK062, a small chemical molecule, inhibits cancer upregulated gene 2-induced oncogenesis through NEK2 and β-catenin
por: Kaowinn, Sirichat, et al.
Publicado: (2019)

Nek5: a new regulator of centrosome integrity
por: Prosser, Suzanna L., et al.
Publicado: (2015)

Fractionation-Dependent Radiosensitization by Molecular Targeting of Nek1
por: Freund, Isabel, et al.
Publicado: (2020)

Checking NEKs: Overcoming a Bottleneck in Human Diseases
por: Peres de Oliveira, Andressa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_16o73n6dr7qs3olkniihsd0it2